HOPE IN ACTION
An Evening for Frizzle
SAVE THE DATE
Wednesday, May 20, 2026
6:30pm-9:30pm
Rooftop, Macquarie Group Limited
660 Fifth Avenue, New York, NY, 10103 US
Please save the date for a special evening bringing together friends, partners, and supporters of Finding Hope for Frizzle (FRRS1L).
This event will support the final funding needed to complete manufacturing and launch the first clinical trial for children with Frizzle disease, with patient dosing planned for September 2026. Join us to learn more about the progress made, the path ahead, and how this community can help bring a potential first treatment to children and families who urgently need it.
Invitation to follow in April.
HELP FUND THE CURE
These sweet, but struggling children, now have HOPE that treatment is possible that will save their lives and change the world, but we need your help to fund it.
2026 the Year for Frizzle Treatment
But only with your support!
Our goal is to begin treating Frizzle patients by September of this year with a one-time gene replacement therapy.
We have a clear plan, committed partners, and a defined timeline. What remains is raising the funds needed to bring this treatment across the finish line and into patients.
We must raise $4 million to cover both the manufacturing of the drug and the costs of treating patients in a clinical trial.
Every donation goes directly toward changing lives and changing the world!
Pre-clinical Data shows Restoration of Function
Our pre-clinical research on FRRS1L mouse models showed the recovery of function through gene replacement therapy. The gene replacement therapy given to FRRS1L diseased mice worked to bring function back to FRRS1L diseased mice brains and bodies! This is life changing news! We want recover for Frizzle patients and are working to get treatment developed this year. Would you join us in making treatment a reality for sick Frizzle patients this year?
Donate today to help us fund treatment development for Frizzle patients!
Treatment by September 2026 is possible with your support!
Our race to treatment has begun. We have a goal to begin treating Frizzle patients by Sept. 2026, but it will only happen with your support! Donate today to help fund the manufacturing of the drug that will be a one time injection for Frizzle patients!
All donations are tax deductible, and go directly to fund the development of FRRS1L gene therapy treatment. Your gift will help ALL children with FRRS1L. That is older children who have lost hope, younger children who haven’t yet regressed, and unborn children who will inherit this disorder. This research also moves forward the science that may result in cures for other genetic diseases.